Tissue inhibitor of metalloproteinases-1 (TIMP1), which prevents the degradation of the ECM by inhibiting members of a large family of MMPs, has also been shown to increase in the development of liver fibrosis both in murine experimental models and human samples34,35. This evidence concerns the gene TIMP1 and Hepatic fibrosis.